EUVIMEDEUVIMED entdecken
Crossref

Preliminary Study of a Novel 68 Ga-Labeled Probe Targeting Neuropilin-1 for Tumor Diagnosis

Shuyue Cai, Rui Tang, Jichen Yang, Manxuan Ge, Yuxuan Zhou, Quan Xie, Qingzhu Liu, Ling Qiu, Jianguo Lin iD

Molecular Pharmaceutics · 2025

DOI: 10.1021/acs.molpharmaceut.4c01406 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Shuyue Cai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiopharmaceuticals, School of Pharmacy, Nanjing Medical University, Nanjing 211166, China. Hauptthemen laut MEDLINE: Neuropilin-1, Gallium Radioisotopes, Radiopharmaceuticals, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China, Wuxi Municipal Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuropilin-1 (NRP-1), a transmembrane protein related to tumor progression and invasion, presents potential as a prospective biomarker for tumor diagnosis and therapy. Positron emission tomography (PET) is acknowledged as an ideal modality for accurately monitoring NRP-1 expression in vivo due to its superior sensitivity and resolution. In this study, a novel peptide-based PET imaging probe, [ 68 Ga]Ga-DOTA-NEP, was successfully developed for specifically visualizing NRP-1 expression in tumors. The probe was prepared with a radiochemical yield (RCY) and radiochemical purity (RCP) greater than 95%, a molar activity of 13.28 ± 0.97 GBq/μmol, and a lipid–water partition coefficient (log P ) of −2.20 ± 0.13. In vitro stability assay showed that the probe possessed sufficient stability for biological evaluation. The cellular uptake of the probe in U87 and A549 cells (4.91 ± 0.14 and 4.58 ± 0.40%AD) with high expression of NRP-1 was higher than that observed in NRP-1 negative cells HCT116 and NCI-H1299 (2.84 ± 0.23 and 1.76 ± 0.25%AD) at 1 h. In vivo PET imaging revealed that the maximum tumor uptake of the probe in U87 (7.20 ± 1.03%ID/mL) and A549 (5.90 ± 0.57%ID/mL) tumor-bearing mice was also markedly higher compared to that in HCT116 (3.09 ± 0.43%ID/mL) and NCI-H1299 (2.90 ± 0.70%ID/mL) tumor-bearing mice. Ex vivo analysis further confirmed the targeting specificity of the probe [ 68 Ga]Ga-DOTA-NEP for NRP-1. These results suggest that [ 68 Ga]Ga-DOTA-NEP could serve as a promising PET imaging probe for the diagnosis of NRP-1 positive tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuropilin-1Gallium RadioisotopesRadiopharmaceuticalsNeoplasmsHumansAnimalsMicePositron-Emission TomographyCell Line, TumorTissue DistributionMice, NudeMice, Inbred BALB CA549 CellsFemale

Stichwörter der Autor:innen

NRP-1imaging probepositron emission tomography (PET)tumor diagnosis

Substanzen

Neuropilin-1Gallium RadioisotopesRadiopharmaceuticals

Autor:innen und Institutionen

  • Department of Radiopharmaceuticals, School of Pharmacy, Nanjing Medical University, Nanjing 211166, China.
  • NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi 214063, China.

ORCID-Profile: Jianguo Lin

Förderung

  • Natural Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China
  • Wuxi Municipal Health Commission

Zitieren

APA

Cai, S., Tang, R., Yang, J., Ge, M., Zhou, Y., Xie, Q., Liu, Q., Qiu, L., & Lin, J. (2025). Preliminary Study of a Novel 68 Ga-Labeled Probe Targeting Neuropilin-1 for Tumor Diagnosis. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c01406

Vancouver

Cai S, Tang R, Yang J, Ge M, Zhou Y, Xie Q, et al. Preliminary Study of a Novel 68 Ga-Labeled Probe Targeting Neuropilin-1 for Tumor Diagnosis. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.4c01406

BibTeX
@article{Cai2025,
  author = {Cai, Shuyue and Tang, Rui and Yang, Jichen and Ge, Manxuan and Zhou, Yuxuan and Xie, Quan and Liu, Qingzhu and Qiu, Ling and Lin, Jianguo},
  title = {Preliminary Study of a Novel 68 Ga-Labeled Probe Targeting Neuropilin-1 for Tumor Diagnosis},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  doi = {10.1021/acs.molpharmaceut.4c01406}
}
Kostenlos starten →